Demetrix Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 103

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $50M

  • Investors
  • 5

Demetrix General Information

Description

Developer of a fermentation system designed to create natural medicines. The company's system uses genetics and computing-enabled deciphering technology to produce co-evolved and bio-inspired cannabinoids medicines and nutraceuticals in genetics, synthetic biology, and data science, enabling physicians to understand and harvest biology into bio-inspired medicines and nutraceuticals for gene synthesis.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 25801 Industrial Boulevard
  • A-200
  • Hayward, CA 94545
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 25801 Industrial Boulevard
  • A-200
  • Hayward, CA 94545
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Demetrix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series A) 10-Feb-2021 $50M Completed Generating Revenue
2. Seed Round 07-Jan-2019 Completed Generating Revenue
1. University Spin-Out 01-Jan-2017 Completed Startup
To view Demetrix’s complete valuation and funding history, request access »

Demetrix Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
Seed
To view Demetrix’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Demetrix Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a fermentation system designed to create natural medicines. The company's system uses genetics and computin
Drug Discovery
Hayward, CA
103 As of 2022

Houston, TX
 

San Diego, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Demetrix Competitors (8)

One of Demetrix’s 8 competitors is GlycosBio, a Venture Capital-Backed company based in Houston, TX.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
GlycosBio Venture Capital-Backed Houston, TX
Renew Biopharma Corporation San Diego, CA
BioMediCan Venture Capital-Backed Fremont, CA
Hyasynth Venture Capital-Backed Montreal, Canada
Cellibre Venture Capital-Backed San Diego, CA
You’re viewing 5 of 8 competitors. Get the full list »

Demetrix Patents

Demetrix Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230082130-A1 Use of cannabinoid compounds to treat or prevent fungal growth of c. albicans Inactive 07-Sep-2021
WO-2023039421-A1 Use of cannabinoid compounds to treat or prevent fungal growth of c. albicans Inactive 07-Sep-2021
WO-2023009876-A1 Improving the stability of non-petroleum oils using cannabinoid compounds to provide antioxidative betefits Inactive 30-Jul-2021
US-20230044714-A1 Stability of non-petroleum oils using cannabinoid compounds to provide antioxidative benefits Inactive 30-Jul-2021
US-20230037975-A1 Use of cannabinoid compounds in oral care compositions to inhibit the growth of p. gingivalis Inactive 30-Jul-2021 A61K8/347
To view Demetrix’s complete patent history, request access »

Demetrix Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Demetrix Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angel (individual) Minority
Pandect / Berkeley Catalyst Fund Venture Capital Minority
Tuatara Capital PE/Buyout Minority
Horizons Ventures Venture Capital Minority
University of California, Berkeley University
To view Demetrix’s complete investors history, request access »

Demetrix FAQs

  • When was Demetrix founded?

    Demetrix was founded in 2017.

  • Where is Demetrix headquartered?

    Demetrix is headquartered in Hayward, CA.

  • What is the size of Demetrix?

    Demetrix has 103 total employees.

  • What industry is Demetrix in?

    Demetrix’s primary industry is Drug Discovery.

  • Is Demetrix a private or public company?

    Demetrix is a Private company.

  • What is the current valuation of Demetrix?

    The current valuation of Demetrix is .

  • What is Demetrix’s current revenue?

    The current revenue for Demetrix is .

  • How much funding has Demetrix raised over time?

    Demetrix has raised $61M.

  • Who are Demetrix’s investors?

    , Pandect / Berkeley Catalyst Fund, Tuatara Capital, Horizons Ventures, and University of California, Berkeley have invested in Demetrix.

  • Who are Demetrix’s competitors?

    GlycosBio, Renew Biopharma, BioMediCan, Hyasynth, and Cellibre are some of the 8 competitors of Demetrix.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process